Inotek Pharmaceuticals (United States)
Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Inotek Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
40%
Total
Publications
258
Total Open
Publications
102
Total
Citations
19K
Open Access
Percentage
40%
Total
Publications
258
Total Open
Publications
102
Total
Citations
19K
Breakdown
Publisher Open
24%
Both
7%
Other Platform Open
9%
Closed
60%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 15%
12
Hybrid 15%
12
No Guarantees 70%
55
Other Platform Open
Domain 76%
31
Institution 27%
11
Public 2%
1
Other Internet 2%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 30 |
Europe PMC | Domain | 24 |
Université de Lausanne - SERVAL | Institution | 3 |
University of Debrecen - University of Debrecen Electronic Archive | Institution | 3 |
University of Michigan - Deep Blue | Institution | 2 |
Figshare | Public | 2 |
University of Toronto - TSpace | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |
Universitat Politècnica de València - Repositorio Institucional de la Universitat Politècnica | Institution | 1 |
CiteSeer X | Other Internet | 1 |